Roivant grants director 10,531 options, 5,054 RSUs
Roivant director Melissa B. Epperly received annual RSU and stock option awards that fully vest in 2027, increasing her direct equity stake.
Rhea-AI Filing Summary
Roivant Sciences Ltd. (ROIV) reported that director Melissa B. Epperly received annual equity awards on September 16, 2026. She was granted 10,531 stock options to purchase Common Shares at an exercise price of $39.57 per share and 5,054 restricted stock units, all as direct holdings. The RSUs and the options are scheduled to vest 100% on September 16, 2027, subject to her continued service as a director. Following these awards, she directly holds 14,954 Common Shares and 10,531 options.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 15,585 shares
Grant/Award
2 txns
Insider
Epperly Melissa B,
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) F2 | 10,531 | $0.00 | $0.00 |
| Grant/Award | Common Shares F1 | 5,054 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 10,531 contracts (Direct);
Common Shares — 14,954 shares (Direct)
Footnotes (2)
- F1. Reflects an annual award of restricted stock units with respect to Common Shares ("RSUs") granted pursuant to the Company's 2021 Equity Incentive Plan and the Company's Non-Employee Director Compensation Policy. The award of RSUs is scheduled to vest 100% on September 16, 2027, subject generally to the reporting person's service as a director through such date.
- F2. Reflects an annual award of stock options to purchase Common Shares granted pursuant to the Company's 2021 Equity Incentive Plan and the Company's Non-Employee Director Compensation Policy. The award of stock options is scheduled to vest and become exercisable 100% on September 16, 2027, subject generally to the reporting person's service as a director through such date.
Key Figures
RSUs granted: 5,054 RSUs
Stock options granted: 10,531 options
Option exercise price: $39.57 per share
+4 more
7 metrics
RSUs granted
5,054 RSUs
Annual award of restricted stock units granted September 16, 2026
Stock options granted
10,531 options
Annual stock option award granted September 16, 2026
Option exercise price
$39.57 per share
Exercise price for options to purchase Roivant Common Shares
Common Shares held after award
14,954 shares
Direct Roivant Common Share holdings after RSU grant
Options held after award
10,531 options
Direct options position following the September 16, 2026 grant
Vesting date
September 16, 2027
Scheduled vesting for both RSUs and stock options, subject to continued service
Option expiration date
September 15, 2036
Expiration date for the granted stock options
Key Terms
restricted stock units, 2021 Equity Incentive Plan, Non-Employee Director Compensation Policy, stock options, +1 more
5 terms
restricted stock units financial
"Reflects an annual award of restricted stock units with respect to Common Shares"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
2021 Equity Incentive Plan financial
"granted pursuant to the Company's 2021 Equity Incentive Plan"
Non-Employee Director Compensation Policy financial
"and the Company's Non-Employee Director Compensation Policy"
stock options financial
"Reflects an annual award of stock options to purchase Common Shares"
Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.
vesting financial
"The award of RSUs is scheduled to vest 100% on September 16, 2027"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity awards did Roivant Sciences (ROIV) grant to director Melissa B. Epperly?
Melissa B. Epperly received 5,054 RSUs and 10,531 stock options on September 16, 2026, under Roivant’s 2021 Equity Incentive Plan and Non-Employee Director Compensation Policy, all as direct holdings.
What is the exercise price of Melissa B. Epperly’s new Roivant (ROIV) stock options?
The new stock options granted to Melissa B. Epperly carry an exercise price of $39.57 per Common Share, with a scheduled expiration date of September 15, 2036, and they vest 100% on September 16, 2027, subject to continued board service.
When do Melissa B. Epperly’s new Roivant (ROIV) RSUs and options vest?
Both the 5,054 RSUs and the 10,531 stock options granted to Melissa B. Epperly are scheduled to vest and become exercisable 100% on September 16, 2027, generally conditioned on her continued service as a director through that date.
Were Melissa B. Epperly’s Roivant (ROIV) transactions under a Rule 10b5-1 plan?
No. The filing’s Rule 10b5-1 checkbox is not marked as an affirmative plan, and the footnotes describe these as annual equity awards under the company’s compensation arrangements for non-employee directors.
AI-generated analysis. How Rhea-AI works. Not financial advice.
